Nipah survivors study to advance new vaccines against highly fatal threat
CEPI will expand its partnership with icddr,b in Bangladesh, providing near to the additional US $ 1 million in funding to advance understanding of the Nipah virus
CEPI will expand its partnership with icddr,b in Bangladesh, providing near to the additional US $ 1 million in funding to advance understanding of the Nipah virus
Nipah virus (NiV) is an emerging zoonotic disease that causes severe disease in humans. Signs and symptoms range from asymptomatic to acute respiratory infection and fatal encephalitis
BIL also holds an option to increase its equity stake by an additional 15%
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
The emergence of new infections in India is a growing concern
India boasts the largest livestock population, with 536 million livestock and 851 million poultry
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
Subscribe To Our Newsletter & Stay Updated